__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
You can access the MAYZENT risk management resources below, which will help you initiate and manage your SPMS patients with active disease.
If you would like to receive printed copies of any of these materials, please contact your local MAYZENT key account manager.
PRESCRIBER’S CHECKLIST
A checklist of important points to remember before, during and after treatment with MAYZENT.
The link below will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
SUMMARY OF PRODUCT CHARACTERISTICS FOR MAYZENT
The ‘view’ link below will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
MAYZENT PATIENT AND CAREGIVER GUIDE
A guide detailing important information about MAYZENT for patients and caregivers.
The ‘view’ link below will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
MAYZENT PREGNANCY CARD
A card detailing information for female patients of childbearing potential.
The ‘view’ link below will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
Indication: MAYZENT is indicated for the treatment of adult patients with SPMS with active disease evidenced by relapses or imaging features of inflammatory activity.1
SPMS, secondary progressive multiple sclerosis.
Reference:
- MAYZENT (siponimod) Summary of Product Characteristics.
